Ph.D., Founder & Chief Scientific Officer, CEPIMP Genomics Argentina
Dr. López-Díaz specializes in the molecular biology of cancer and is a pioneer in clinical genomics implementation and education in Latin America. With a Clinical Biochemistry degree and a PhD in Chemical Sciences from National University of Córdoba- Argentina, in 2005 he moved to The Salk Institute, La Jolla, for his postdoctoral training. There, he developed a cancer research program making groundbreaking contributions to the field. A Salk Staff Scientist since 2013, he participates at the UCSD Cancer Center Molecular Tumor Board since 2014. In 2015, he became Adjunct Professor for the Master in Advanced Therapies at Universidad Francisco de Vitoria, Spain. Recipient of multiple distinctions, has given dozens of lectures worldwide and is member of ASCO, ACMG, AACR and AAAS.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: It is critically important that we all aim for the best possible outcome of care at the lowest possible cost. Value-based healthcare matters to both patients and providers. Value-based healthcare models have the potential to overturn traditional patient care models. Yet, the industry is facing challenges when implementing this new approach. To better understand how other countries are progressing towards value-based healthcare we have a planned a session with a series of global representatives that will discuss their learnings.